593
Views
15
CrossRef citations to date
0
Altmetric
Review

Further understanding of the immunopathology of multiple sclerosis: impact on future treatments

&
Pages 1069-1089 | Received 05 Nov 2015, Accepted 16 May 2016, Published online: 23 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eliza Gordon-Lipkin & Brenda Banwell. (2017) An update on multiple sclerosis in children: diagnosis, therapies, and prospects for the future. Expert Review of Clinical Immunology 13:10, pages 975-989.
Read now

Articles from other publishers (14)

Xingzong Sun, Menghan Qian, Hongliang Li, Lei Wang, Yunjie Zhao, Min Yin, Lili Dai & Hongkun Bao. (2023) FKBP5 activates mitophagy by ablating PPAR-γ to shape a benign remyelination environment. Cell Death & Disease 14:11.
Crossref
Alba Sánchez-Fernández, Stephanie Zandee, Mauricio Mastrogiovanni, Marc Charabati, Homero Rubbo, Alexandre Prat & Rubèn López-Vales. (2022) Administration of Maresin-1 ameliorates the physiopathology of experimental autoimmune encephalomyelitis. Journal of Neuroinflammation 19:1.
Crossref
Xiaoyun Zhang, Ying Song, Xiao Chen, Xiaojia Zhuang, Zhiqiang Wei & Li Yi. (2022) Integration of Genetic and Immune Infiltration Insights into Data Mining of Multiple Sclerosis Pathogenesis. Computational Intelligence and Neuroscience 2022, pages 1-19.
Crossref
SofiaFernanda Gonçalves Zorzella-Pezavento, LuizaAyumi Nishiyama Mimura, MarinaBonifácio Denadai, WilliamDanilo Fernandes de Souza, ThaisFernanda de Campos Fraga-Silva & Alexandrina Sartori. (2022) Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?. Neural Regeneration Research 17:9, pages 1945.
Crossref
Maryam Azimzadeh, Nora Möhn, Sajjad Ghane Ezabadi, Zahra Moghimi Esfandabadi, Alireza Soleimani, Elaheh Ranjbar, Maliheh Jahromi, Reihaneh Seyedebrahimi, Thomas Skripuletz & Farshad Moharrami Kasmaie. (2021) The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic. Biomolecules 11:9, pages 1372.
Crossref
Anil Kumar, Jugal Kishore Das, Hao-Yun Peng, Liqing Wang, Yijie Ren, Xiaofang Xiong & Jianxun Song. 2021. Recent Advances in iPSCs for Therapy, Volume 3. Recent Advances in iPSCs for Therapy, Volume 3 315 338 .
Bodhraj Acharya, Rakeshchandra R. Meka, Shivaprasad H. Venkatesha, Jason R. Lees, Tambet Teesalu & Kamal D. Moudgil. (2020) A novel CNS-homing peptide for targeting neuroinflammatory lesions in experimental autoimmune encephalomyelitis. Molecular and Cellular Probes 51, pages 101530.
Crossref
Maria Grazia Celani, Marta Melis, Massimiliano Orso, Maria Vittoria Ercolani & Teresa Anna Cantisani. (2020) Cladribine for people with multiple sclerosis. Cochrane Database of Systematic Reviews.
Crossref
Alba Sánchez-Fernández, Damaris B. Skouras, Charles A. Dinarello & Rubèn López-Vales. (2019) OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis. Frontiers in Immunology 10.
Crossref
Yasmine Probst, Erin Mowbray, Erika Svensen & Keats Thompson. (2019) A Systematic Review of the Impact of Dietary Sodium on Autoimmunity and Inflammation Related to Multiple Sclerosis. Advances in Nutrition 10:5, pages 902-910.
Crossref
Shivaprasad H. Venkatesha & Kamal D. Moudgil. (2019) Celastrol suppresses experimental autoimmune encephalomyelitis via MAPK/SGK1-regulated mediators of autoimmune pathology. Inflammation Research 68:4, pages 285-296.
Crossref
Xuemei Qiu, Hui Luo, Xue Liu, Qingqing Guo, Kang Zheng, Danping Fan, Jiawen Shen, Cheng Lu, Xiaojuan He, Ge Zhang & Aiping Lu. (2018) Therapeutic Potential of Pien Tze Huang on Experimental Autoimmune Encephalomyelitis Rat. Journal of Immunology Research 2018, pages 1-10.
Crossref
Laura M. Jacobsen, Amanda Posgai, Howard R. Seay, Michael J. Haller & Todd M. Brusko. (2017) T Cell Receptor Profiling in Type 1 Diabetes. Current Diabetes Reports 17:11.
Crossref
Nahid Mohammadi, Fatemeh Takarli, Masoud Khodaveisi & Ali Reza Soltanian. (2017) The Effect of Peer Educational Program on the Self-Efficacy of Multiple Sclerosis Patients: A Randomized‐Controlled Trial. Scientific Journal of Hamedan Nursing and Midwifery Faculty 25:2, pages 36-44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.